Oxycodone and Aspirin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Oxycodone Hydrochloride; Aspirin.
| Product ID | 0591-3551_0c3167ea-b863-485b-b18e-e7835803c9cb |
| NDC | 0591-3551 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxycodone and Aspirin |
| Generic Name | Oxycodone And Aspirin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-10-18 |
| Marketing End Date | 2020-06-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090084 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | OXYCODONE HYDROCHLORIDE; ASPIRIN |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Marketing Start Date | 2011-10-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090084 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-18 |
| Marketing End Date | 2020-06-30 |
| Ingredient | Strength |
|---|---|
| OXYCODONE HYDROCHLORIDE | 4.8355 mg/1 |
| SPL SET ID: | a598f735-d2e2-43ad-be77-8627ea4a9b78 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| Pharm Class PE | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0591-3551 | Oxycodone and Aspirin | Oxycodone and Aspirin |
| 68308-845 | Oxycodone and Aspirin | Oxycodone Hydrochloride and Aspirin |